Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.

Respir Res · 2017 · PMC5392996 · PMID 28416015

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

AATD patients, both with and without AT, tended to have lower total costs compared to COPD patients without AATD, but these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.